Decide at what price you'd be comfortable buying and we'll help you stay ready.
Recordati Industria Chimica e Farmaceutica is an Italian pharmaceutical company that develops, manufactures, and sells branded medicines. Its portfolio includes prescription drugs for specialty and rare conditions, along with some consumer healthcare products. It does not mainly sell generic bulk medicine; instead, it focuses on specific treatments where doctors, pharmacies, and hospitals need reliable branded products.
The company makes money by selling these medicines through pharmacies, hospitals, distributors, and healthcare providers in Europe and other markets. It also earns from licensing and other pharmaceutical partnerships when it lets partners use its products or know-how in certain countries. That mix gives it a business based on repeat demand for established treatments rather than one-time product sales.
What makes Recordati different is its focus on smaller therapeutic niches where a drug maker can build deep expertise and a strong position over time. In practice, it acts as a specialist supplier in the healthcare value chain: it develops or acquires medicines, produces them, and then sells them under its own brands to patients and professionals through the healthcare system.
Alpha Spread
Preferences
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
New to Alpha Spread? Create free account
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more